Is BioNexus Gene Lab Corp. (BGLC) a Buy, Sell, or Hold?
NASDAQ : BGLC
BioNexus Gene Lab Corp. — Earnings Estimates
$1.6 USD
$0.04 (2.56%)
- Volume
- 1.81K
- Average Volume
- 99.31K
- Market Capitalization
- $3.22M
- P/E Ratio
- -1.08
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $8.98
- Year Low
- $1.07
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $6.52
Annual earnings financials
BGLC financial data with annual/quarterly toggle
Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.